- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/42 - Benzene-sulfonamido pyrazoles
Patent holdings for IPC class C07D 231/42
Total number of patents in this class: 56
10-year publication summary
|
2
|
4
|
3
|
2
|
1
|
7
|
2
|
1
|
4
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ChemoCentryx, Inc. | 358 |
6 |
| Biofront Ltd. (Cayman) | 17 |
4 |
| The Penn State Research Foundation | 1648 |
3 |
| Hoffmann-La Roche Inc. | 3876 |
2 |
| Board of Regents, The University of Texas System | 6206 |
2 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2326 |
2 |
| Dompé Farmaceutici S.p.A. | 305 |
2 |
| Elara Pharmaceuticals GmbH | 9 |
2 |
| European Molecular Biology Laboratory (embl) | 22 |
2 |
| Sanford-Burnham Medical Research Institute | 122 |
2 |
| University of Dundee | 221 |
2 |
| Shanghai Yidi Biotechnology Co., Ltd. | 12 |
2 |
| Biofront Ltd | 10 |
2 |
| F. Hoffmann-La Roche AG | 7784 |
1 |
| Novartis Pharma AG | 285 |
1 |
| The Regents of the University of California | 20987 |
1 |
| Genentech, Inc. | 4161 |
1 |
| Bayer Cropscience AG | 1819 |
1 |
| Glaxosmithkline Intellectual Property Development Limited | 783 |
1 |
| Vertex Pharmaceuticals Incorporated | 1578 |
1 |
| Other owners | 16 |